NewsBenzinga클리어마인드 메디슨, LSD·케타민·이보가인과 팔미토일에탄올아미드 등 N-아실에탄올아민의 독점적 조합에 관한 3건의 미국 특허 출원 발표 클리어마인드 메디슨, LSD·케타민·이보가인과 팔미토일에탄올아미드 등 N-아실에탄올아민의 독점적 조합에 관한 3건의 미국 특허 출원 발표 Benzinga 2026.09.23 11:59 (GMT+0) Open on Benzinga Other news Hyperscale Data completes tokenization of 5,000 troy ounces of silver; AI subsidiary askROI plans listing in Q2 or Q3 2027 Specter retweet warns community that InfoFi project BILL is a suspected scam, token price has plunged 97% from its high First Financial: Acquisitions Drive 2027 Growth (NASDAQ:THFF) OpenAI ramps up humanoid robot R&D, making AI brain the core breakthrough Nvidia denies RTX 5090 production halt: just insufficient capacity, no supply cut Weekly Closed-End Fund Roundup (October 11, 2026)
Hyperscale Data completes tokenization of 5,000 troy ounces of silver; AI subsidiary askROI plans listing in Q2 or Q3 2027
Specter retweet warns community that InfoFi project BILL is a suspected scam, token price has plunged 97% from its high
